Abbott Laboratories (ABT) Ownership
ABT ownership summary
as of October 18, 2026- Institutions
- 81.8% of shares outstanding
- Insiders
- 0.49% of shares outstanding
- Shares outstanding
- 1.73B
- Float
- 1.72B shares available to trade
- Short interest
- 0.88% 13.6M shares short
- Days to cover
- 1.57 short interest down 38.4% vs prior month
- Institutions 81.85%
- Insiders 0.49%
- Other investors 17.66%
ABT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.82% | 152.6M | $16.00B | +6.9M (+4.7%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 6.57% | 113.8M | $11.93B | +801,061 (+0.7%) | June 30, 2026 |
| 3 | State Street Corp | 4.68% | 80.9M | $8.49B | +1.4M (+1.7%) | June 30, 2026 |
| 4 | Charles Schwab Investment Management Inc | 3.45% | 59.7M | $6.26B | +14.2M (+31.2%) | June 30, 2026 |
| 5 | Vanguard Portfolio Management, LLC | 2.83% | 49.0M | $5.14B | +1.1M (+2.2%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 2.27% | 39.2M | $4.11B | +70,542 (+0.2%) | June 30, 2026 |
| 7 | Capital Research Global Investors | 2.13% | 36.9M | $3.87B | −12.9M (−25.8%) | June 30, 2026 |
| 8 | Capital Research & Mgmt Co - Division 3 | 2.00% | 34.7M | $3.63B | −2.8M (−7.6%) | June 30, 2026 |
| 9 | Morgan Stanley - Brokerage Accounts | 1.54% | 26.6M | $2.79B | −3.5M (−11.6%) | June 30, 2026 |
| 10 | NORGES BANK | 1.35% | 23.4M | $2.45B | −101,803 (−0.4%) | June 30, 2026 |
| 11 | T. Rowe Price Associates, Inc. | 1.32% | 22.8M | $2.39B | +5.5M (+31.9%) | June 30, 2026 |
| 12 | Franklin Templeton Inc | 1.09% | 18.8M | $1.97B | −1.2M (−6.1%) | June 30, 2026 |
| 13 | Northern Trust Corp | 1.06% | 18.3M | $1.92B | −1.1M (−5.8%) | June 30, 2026 |
| 14 | Bank of America Corp | 1.02% | 17.7M | $1.85B | −1.6M (−8.3%) | June 30, 2026 |
| 15 | The Goldman Sachs Group Inc | 0.97% | 16.8M | $1.76B | +2.3M (+15.5%) | June 30, 2026 |
| 16 | Deutsche Bank AG | 0.97% | 16.7M | $1.75B | +2.6M (+18.6%) | June 30, 2026 |
| 17 | Wells Fargo & Co | 0.88% | 15.2M | $1.59B | −732,024 (−4.6%) | June 30, 2026 |
| 18 | JPMorgan Chase & Co | 0.87% | 15.1M | $1.58B | −11.7M (−43.6%) | June 30, 2026 |
| 19 | State Farm Mutual Automobile Ins Co | 0.79% | 13.6M | $1.43B | — | June 30, 2026 |
| 20 | FMR Inc | 0.78% | 13.4M | $1.41B | +2.6M (+23.8%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 37.3M shares and 9 cut 35.7M.
ABT top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.20% | 55.4M | $5.81B | −108,706 (−0.2%) | August 31, 2026 |
| 2 | Vanguard 500 Index Investor | 2.63% | 45.4M | $4.77B | −833,945 (−1.8%) | September 30, 2026 |
| 3 | Schwab US Dividend Equity ETF™ | 2.40% | 41.5M | $4.36B | +115,184 (+0.3%) | September 30, 2026 |
| 4 | iShares Core S&P 500 ETF | 1.33% | 23.1M | $2.42B | −37,111 (−0.2%) | September 30, 2026 |
| 5 | Fidelity 500 Index | 1.31% | 22.6M | $2.37B | +86,841 (+0.4%) | August 31, 2026 |
| 6 | State Street® SPDR® S&P 500® ETF | 1.23% | 21.2M | $2.23B | — | September 30, 2026 |
| 7 | American Funds Washington Mutual A | 1.01% | 17.5M | $1.84B | −367,231 (−2.1%) | September 30, 2026 |
| 8 | Vanguard MStar Value Index Investor | 0.95% | 16.5M | $1.73B | −168,703 (−1.0%) | September 30, 2026 |
| 9 | State Street®HlthCrSelSectSPDR®ETF | 0.71% | 12.3M | $1.29B | +38,176 (+0.3%) | September 30, 2026 |
| 10 | American Funds Invmt Co of Amer A | 0.63% | 11.0M | $1.15B | +641,786 (+6.2%) | September 30, 2026 |
| 11 | American Funds American Mutual A | 0.58% | 10.0M | $1.05B | +3.7M (+59.4%) | September 30, 2026 |
| 12 | Vanguard Dividend Appreciation ETF | 0.57% | 9.8M | $1.03B | −69,844 (−0.7%) | September 30, 2026 |
| 13 | Vanguard Institutional Index I | 0.53% | 9.2M | $960.1M | −157,843 (−1.7%) | September 30, 2026 |
| 14 | American Funds Capital Inc Bldr A | 0.49% | 8.5M | $895.9M | +2.7M (+45.6%) | September 30, 2026 |
| 15 | MFS Value A | 0.46% | 7.9M | $828.1M | +1.1M (+16.0%) | August 31, 2026 |
| 16 | Vanguard High Dividend Yield ETF | 0.41% | 7.0M | $739.3M | +19,447 (+0.3%) | September 30, 2026 |
| 17 | iShares US Medical Devices ETF | 0.36% | 6.3M | $661.4M | +110,376 (+1.8%) | September 30, 2026 |
| 18 | JPMorgan Equity Income I | 0.36% | 6.3M | $656.4M | +413,408 (+7.1%) | August 31, 2026 |
| 19 | Vanguard Health Care Inv | 0.36% | 6.2M | $653.0M | −2.0M (−24.6%) | June 30, 2026 |
| 20 | American Funds Cptl Wld Gr&Inc A | 0.32% | 5.6M | $584.3M | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ABT insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | Ro Khanna | Sell | $101.85 | — | — |
| 2026-03-24 | Laura Friedman | Sell | $104.10 | — | — |
| 2026-03-23 | Ro Khanna | Buy | $104.87 | — | — |
| 2026-03-19 | Richard McCormick | Buy | $107.16 | — | — |
| 2026-03-10 | Ro Khanna | Buy | $110.60 | — | — |
| 2026-03-02 | Daniel Gesua Sive Salvadori | Sell | $115.58 | 885 | $102,288 |
| 2026-03-02 | Elizabeth C Cushman | Sell | $115.58 | 263 | $30,398 |
| 2026-03-02 | Eric Shroff | Sell | $115.58 | 709 | $81,946 |
| 2026-03-02 | John A Jr. Mccoy | Sell | $115.58 | 585 | $67,614 |
| 2026-03-02 | Mary K Moreland | Sell | $115.58 | 613 | $70,851 |
| 2026-02-27 | Michael T. McCaul | Sell | $116.17 | — | — |
| 2026-02-24 | Ro Khanna | Buy | $114.65 | — | — |
| 2026-02-18 | Ro Khanna | Sell | $113.32 | — | — |
| 2026-02-17 | Ro Khanna | Sell | $112.27 | — | — |
| 2026-02-10 | Gilbert Ray Cisneros, Jr. | Sell | $112.23 | — | — |
| 2026-02-05 | Michael T. McCaul | Buy | $109.03 | — | — |
| 2026-02-04 | Daniel J Starks | Buy | $108.73 | 10,000 | $1.1M |
| 2026-01-29 | Ro Khanna | Sell | $106.03 | — | — |
| 2026-01-29 | Thomas H. Kean, Jr. | Buy | $106.03 | — | — |
| 2026-01-23 | Ro Khanna | Sell | $107.46 | — | — |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ABT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ABT
Institutional investors own 81.8% of Abbott's shares and insiders 0.49%. The largest holder is BlackRock Inc with 8.82% of the shares (152.6M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 9 reduced their stake in the latest filings. Short interest is 0.88% of the float, or 1.57 days of average trading volume. The share count rose 14.8% since 2014.
Related: ABT analyst forecast, ABT key metrics, ABT dividend history. See the ABT stock overview for the latest quote and news.
ABT ownership FAQ
Who owns the most Abbott stock?
The largest shareholders of Abbott are BlackRock Inc (8.82%), Vanguard Capital Management, LLC (6.57%), State Street Corp (4.68%), Charles Schwab Investment Management Inc (3.45%), Vanguard Portfolio Management, LLC (2.83%).
What percentage of Abbott is owned by institutions?
Institutions hold 81.8% of Abbott's shares outstanding; insiders hold 0.49%.
Which funds own Abbott?
The largest fund holders of Abbott are Vanguard MStar Total Stk Mkt Idx Invest (3.20%), Vanguard 500 Index Investor (2.63%), Schwab US Dividend Equity ETF™ (2.40%), iShares Core S&P 500 ETF (1.33%), Fidelity 500 Index (1.31%).
What is Abbott's short interest?
13.6M shares of Abbott were sold short, 0.88% of the float; at the average daily volume it would take 1.57 days to cover.
Are insiders buying or selling Abbott?
Of the latest 20 reported insider transactions in Abbott (since January 23, 2026), 7 were purchases and 13 were sales.
How many shares of Abbott are outstanding?
Abbott has 1.73B shares outstanding, of which 1.72B are in the public float.